ARTICLE | Product Development
Animal studies show Sinovac’s COVID-19 vaccine is protective, does not cause ADE
BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
April 22, 2020 1:40 AM UTC
Updated on Apr 23, 2020 at 12:04 PM UTC
Less than one week after entering the clinic, Sinovac became the first company to report animal data supporting its COVID-19 vaccine candidate.
Sinovac Biotech Ltd. (NASDAQ:SVA) has PiCoVacc in a Phase I/II study and expects to start Phase III testing this year. ...
BCIQ Company Profiles